m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
/MF-Logo-img/73700.png

WhiteOak Capital Pharma and Healthcare Fund-Reg (G)

Sectoral / Thematic
  • NAV

    14.24(-0.20%)
  • Fund Size (CR)

    ₹442.67
  • Expense Ratio

    2.38
  • Scheme Type

    Active Fund
  • Value Research

  • Min. investment

    ₹500
  • Minimum Additional Investment

    ₹500
  • Minimum SIP Investment

    ₹100
  • Minimum Withdrawal

    ₹500
  • Exit Load In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed / switched-out within 1 month from the date of allotment. No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment.

    1%
  • Return Since Launch

    22.45%
  • 3M
  • 6M
  • 1Y
  • 3Y
  • All
Absolute Return: 2.83%
Annualized Return: 0% [object Object]

Basic Details

Scheme Manager

Ramesh Mantri

Bench Mark

BSE Healthcare TRI

Type

OPEN

Lumpsum Returns

Period Invested For₹10,000 Invested onLatest ValueAbsolute ReturnsAnnualised ReturnsCategory AvgRank within Category
1 Week 28 October 202510107.901.08%--0.27%62/928
1 Month3 October 202510412.434.12%-2.35%84/920
3 Month4 August 202510221.092.21%-4.14%715/908
6 Month2 May 202511126.8311.27%-10.50%285/864
1 Year4 November 202410852.908.53%8.53%5.26%202/766
3 Year------/-
5 Year------/-
Since Inception6 February 202414239.0042.39%22.45%13.69%88/936

Note: Lumpsum Returns since Inception Date.

SIP Returns

Period Invested For₹10,000 Invested onInvestmentsLatest ValueAbsolute ReturnsAnnualised Returns
1 Year4 November 20241,30,000139991.227.69% 7.69%
3 Year-----
5 Year-----
10 Year-----

Note: SIP Returns since Inception Date.

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Mutual Funds Calculator

  • Investment type
  • Scheme based
  • SIP
  • Lumpsum

Monthly Investment (₹)

Expected Returns Rate (%)

Time Period (in Years)

  • Invested Amount

    25,000

  • Estimated Returns

    19,059

76%

Returns

Future value of your investment

44,059

Risk Ratios

4.96%

Standard Deviation

0.83%

Beta

0.80%

Sharpe Ratio

0.01%

Treynor's Ratio

12.57%

Jension's Alpha

Asset Allocation

Sector Allocation

Top 10 stock holding in portfolio

Stock Invested in% of Total HoldingsQuantityValue (Cr)Asset TypeSegment
J B Chemicals &6.94%17962230.71EquityPharmaceuticals
Sun Pharma.Inds.6.81%18903630.14EquityPharmaceuticals
Fortis Health.6.69%30520929.60EquityHealthcare
Cipla4.56%13416120.17EquityPharmaceuticals
Laurus Labs4.28%22520818.96EquityPharmaceuticals
Krishna Institu.4.09%25854318.10EquityHealthcare
Neuland Labs.3.20%969814.16EquityPharmaceuticals
Max Healthcare3.19%12650914.10EquityHealthcare
Lupin3.14%7268313.89EquityPharmaceuticals
Apollo Hospitals3.05%1821713.50EquityHealthcare

Peer Comparison

Scheme NameValue ResearchAsset Size (Cr)1M3M6M1Y3Y
Nippon India Taiwan Equity Fund - Direct (G)
406.671.34%26.29%63.29%46.69%41.91%
Nippon India Taiwan Equity Fund - Direct (IDCW)
406.671.34%26.29%63.29%46.69%41.91%
Aditya Birla SL International Equity Fund - Direct (G)
266.190.53%9.35%22.20%32.91%19.14%
Aditya Birla SL International Equity Fund - Direct (IDCW)
266.190.53%9.34%22.20%32.91%19.14%
Franklin Asian Equity Fund - Direct (G)
279.133.89%14.85%26.62%24.67%18.76%

List of Schemes under WhiteOak Capital Mutual Fund

News

  • WhiteOak Capital Mutual Fund Announces Resignation of Key Personnel

    WhiteOak Capital Mutual Fund has announced that, Mr. Vaiibhavv Chugh will cease to be the Head ' Sales of WhiteOak Capital Asset Management Limited w.e.f. the close of business hours of September 30, 2025.

    Powered by Capital Market - Live News

  • WhiteOak Capital Mutual Fund announces change in Key Personnel

    WhiteOak Capital Mutual Fund has announced that Mr. Siddhartha Chaturvedi has been appointed as a Chief Information Security Officer on the Board of the Trustee Company with effect from July 01, 2025.

    Details of Mr. Siddhartha Chaturvedi

    Age: 43

    Designation: Chief Information Security Officer

    Qualification : B.Tech. ' Information Technology, CISA, CEH, CND, CCNA (S & R), CCNA (Security), ITIL Foundation, RBI Certified Cyber Security Professional (Under AVTU) Mission, ISEA Certified Cyber Hygiene Practitioner from MeITY

    Experience: 16

    Powered by Capital Market - Live News

Fund House Details & Investment Objective

Date of Incorporation

16 January 2024

Total AUM (Cr)

₹442.67

WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, WhiteOak Capital Mutual Fund. Launched in 16 January 2024, this fund is managed by Ramesh Mantri. With assets under management (AUM) worth ₹442.67 (Cr), as of 4 November 2025, WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 22.45% since its launch.
The current NAV of WhiteOak Capital Pharma and Healthcare Fund-Reg (G) is ₹14.24, as on 4 November 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in WhiteOak Capital Pharma and Healthcare Fund-Reg (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹500.

Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed / switched-out within 1 month from the date of allotment. No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment. The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.

The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 89.10% in Equity, 11.91% in Debt and -1.01% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 54.73% in Pharmaceuticals & Biotech, 30.37% in Healthcare Services, 10.01% in Debt, 1.94% in Industrial Products, 1.24% in Chemicals & Petrochemical